Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

BIIB

Biogen Inc. β€’ Healthcare (#5 of 11)

$183.78
+0.45 (+0.25%)
View:
Close:$183.78
Vol:EXTREME(90%ile)
Ratio:1.14x
|
RSI:47(Neutral)
MACD:↓
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό0 Down3 Hold
Apr 1Canaccord Genuity
–Buy
Apr 1Oppenheimer
–Outperform
Mar 17HSBC
–Reduce
Price Targets
(60d mean: $206, +12.1%)
NEUTRAL
β–²3 Raisesβ–Ό0 Lowers+7.1% avg
Apr 1Canaccord Genuity
$230β†’$245+6.5%
Apr 1Oppenheimer
$250β†’$275+10.0%
Mar 17HSBC
$143β†’$150+4.9%
Trade Setup
Entry$183.78
Target$195.55 (+6.4%)
Stop$172.01
R/R1.00
Risk-6.4%
Conv22 (LOW)
Size37 shares ($6,800)
Risk Metrics
Sharpe (20d)
-1.33Losing
Volatility (20d)
28.2%Normal
Beta (60d)
0.73Defensive
Alpha (20d)
+1.0%In Line
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.